Emerging options for the management of age-related macular degeneration with stem cells

Stem Cells and Cloning: Advances and Applications

Volumn 4, Issue 1, 2011, Pages 1-10

  Mooney, Ingrid ^a   Lamotte, James ^b  

^a Eye Design   (United States)

^b SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

Age related macular degeneration; Pluripotent stem cells; Retinal pigmented epithelium; Stem cells; Transplantation

Indexed keywords

COLLAGENASE 3; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR;

ADULT STEM CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRUCH MEMBRANE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COLOR DISCRIMINATION; DIPLOPIA; EMBRYONIC STEM CELL; EPIRETINAL MEMBRANE; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; INTRAOCULAR LENS DISLOCATION; INTRAOCULAR PRESSURE; INTRARETINAL CYST; IRIS PIGMENTED EPITHELIUM TRANSPLANTATION; LIFESTYLE; LIMBAL EPITHELIAL PROGENITOR CELL; MESENCHYMAL STROMA STEM CELL; MUELLER CELL; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PLURIPOTENT STEM CELL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RECURRENT DISEASE; RETINA DEGENERATION; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA MACULA HOLE; RETINA MACULA TRANSLOCATION; RETINA SURGERY; RETINITIS PIGMENTOSA; REVIEW; RISK FACTOR; STEM CELL TRANSPLANTATION; STROMA CELL; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY; VITREORETINOPATHY;

EID: 79953231668     PISSN: None     EISSN: 11786957     Source Type: Journal    
DOI: 10.2147/SCCAA.S7674     Document Type: Review

References (104)

1. Fine SL, Berger J W, Maguire MG, Ho AC. Age related macular degeneration. N Engl J Med. 2000;342(7):483-492.
2. Fletcher EL. Mechanisms of photoreceptor death during retinal degeneration. Optom Vis Sci. 2010;87(4):269-275.
3. de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355(14):1474-1485.
4. Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969;42(2): 392-403.
5. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44(1):1-29.
6. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123(2):199-206.
7. Weeks DE, Conley YP, Tsai HJ, et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol. 2001; 132(5):682-692.
8. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116(8):1082-1088.
9. Crabb J W, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U SA. 2002;99(23):14682-14687.
10. Li M, Atmaca-Sonmez P, Othman M, et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age related macular degeneration. Nat Genet. 2006;38(9):1049-1054.
11. Hackett SF, Friedman Z, Freund J, et al. A splice variant of trkB and brain-derived neurotrophic factor are co-expressed in retinal pigmented epithelial cells and promote differentiated characteristics. Brain Res. 1998;789(2):201-212.
12. Ishida K, Yoshimura N, Yoshida M, Honda Y, Murase K, Hayashi K. Expression of neurotrophic factors in cultured human retinal pigment epithelial cells. Curr Eye Res. 1997;16(2):96-101.
13. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285(5425): 245-248.
14. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol. 1999;155(2):421-428.
15. Thurston G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003;314(1):61-68.
16. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003;22(1):1-29.
17. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20(3):385-414.
18. Bird AC. The Bowman lecture. Towards an understanding of age-related macular disease. Eye (Lond). 2003;17(4):457-466.
19. Campochiaro PA, Soloway P, Ryan SJ, Miller J W. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis. 1999;5:34.
20. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Over-expression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascu-larization. Am J Pathol. 2000;157(1):135-144.
21. Sengupta N, Caballero S, Mames RN, Timmers AM, Saban D, Grant MB. Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors. Invest Ophthalmol Vis Sci. 2005;46(1):343-348.
22. Sasahara M, Otani A, Yodoi Y, Yoshimura N. Circulating hematopoietic stem cells in patients with idiopathic choroidal neovascularization. Invest ophthalmol Vis Sci. 2009;50(4):1575-1579.
23. Lecomte J, Louis K, Detry B, et al. Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovasculariza-tion. Cell Mol Life Sci. 2010 Aug 11. [Epub ahead of print].
24. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004;242(1):91-101.
25. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14): 1419-1431.
26. Coffey P. Interview: stemming vision loss with stem cells: seeing is believing. Regen Med. 2009;4(4):505-507.
27. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. 1993;231(11): 635-641.
28. Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. 2002;120(4):451-459.
29. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfo-veal choroidal neovascularization. Am J Ophthalmol. 2002;134(4): 560-565.
30. Chen FK, Patel PJ, Uppal GS, Tufail A, Coffey PJ, Da Cruz L. Long-term outcomes following full macular translocation surgery in neovascular age-related macular degeneration. Br J Ophthalmol. 2010;94(10):1337-1343.
31. MacLaren RE, Bird AC, Sathia PJ, Aylward G W. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005;112(12):2081-2087.
32. Chen FK, Uppal GS, MacLaren RE, et al. Long-term visual and micro-perimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin Experiment Ophthalmol. 2009;37(3):275-285.
33. Maaijwee K, Heimann H, Missotten T, Mulder P, Joussen A, van Meurs J. Retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol. 2007;245(11):1681-1689.
34. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002;133(2):215-225.
35. Van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol. 2003;136(4):688-695.
36. MacLaren RE, Uppal GS, Balaggan KS, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114(3):561-570.
37. Klimanskaya I. Retinal pigment epithelium. Methods Enzymol. 2006;418:169-194.
38. Thumann G, Bartz-Schmidt KU, El Bakri H, et al. Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation. 1999;68(2):195-201.
39. Thumann G, Aisenbrey S, Schraermeyer U, et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol. 2000;118(10): 1350-1355.
40. Tezel TH, Del Priore LV. Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. Invest Ophthalmol Vis Sci. 1999;40(3):767-774.
41. Kinouchi R, Takeda M, Yang L, et al. Robust neural integration from retinal transplants in mice defcient in GFAP and vimentin. Nat Neurosci. 2003;6(8):863-868.
42. Wang S, Villegas-Perez MP, Vidal-Sunz M, Lund RD. Progressive optic axon dystrophy and vascular changes in rd mice. Invest Ophthalmol Vis Sci. 2000;41(2):537-545.
43. Lund RD, Ono SJ, Keegan DJ, Lawrence JM. Retinal transplantation: progress and problems in clinical application. J Leukoc Biol. 2003;74(2):151-160.
44. Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Bjorklund A. Site specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci. 1999;19(14):5990-6005.
45. Gage FH. Mammalian neural stem cells. Science. 2000;287(5457): 1433-1438.
46. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25(1):100-106.
47. Haruta M. Embryonic stem cells: potential source for ocular repair. Semin Ophthalmol. 2005;20(1):17-23.
48. Zhao X, Das AV, Bhattacharya S, et al. Derivation of neurons with functional properties from adult limbal epithelium: implications in autologous cell therapy for photoreceptor degeneration. Stem Cells. 2008;26(4):939-949.
49. Zhao X, Liu J, Ahmad I. Differentiation of embryonic stem cells to retinal cells in vitro. Methods Mol Biol. 2006;330: 401-416.
50. Tropepe V, Coles BL, Chiasson BJ, et al. Retinal stem cells in the adult mammalian eye. Science. 2000;287(5460):2032-2036.
51. Klassen HJ, Ng TF, Kurimoto Y, et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci. 2004;45(11):4167-4172.
52. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature. 2006;444(7116): 203-207.
53. Thanos S. Adult retinofugal axons regenerating through peripheral nerve grafts can restore the light-induced pupilloconstriction refex. Eur J Neurosci. 1992;4(8):691-699.
54. Carter DA, Bray GM, Aguayo AJ. Long-term growth and remodeling of regenerated retino collicular connections in adult hamsters. J Neurosci. 1994;14(2):590-598.
55. Carter DA, Bray GM, Aguayo AJ. Regenerated retinal ganglion cell axons can form well differentiated synapses in the superior colliculus of adult hamsters. J Neurosci. 1989;9(11):4042-4050.
56. Keirstead SA, Rasminsky M, Fukuda Y, Carter DA, Aguayo AJ, Vidal-Sanz M. Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons. Science. 1989;246(4927):255-257.
57. Englund U, Fricker-Gates RA, Lundberg C, Bjorklund A, Wictorin K. Transplantation of human neural progenitor cells into neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp Neurol. 2002;173(1):1-21.
58. Ooto S, Akagi T, Kageyama R, et al. Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc Natl Acad Sci U SA. 2004;101(37):13654-13659.
59. Fischer AJ, Reh TA. Müller glia are a potential source of neural regeneration in the postnatal chicken retina. Nat Neurosci. 2001;4(3):247-252.
60. Klassen H, Sakaguchi DS, Young MJ. Stem cells and retinal repair. Prog Retin Eye Res. 2004;23(2):149-181.
61. Lawrence JM, Singhal S, Bhatia B, et al. MIO-M1 cells and similar müller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells. 2007;25(8):2033-2043.
62. Vossmerbaeumer U, Ohnesorge S, Kuehl S, et al. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy. 2009;11(2): 177-188.
63. Tomita M, Adachi Y, Yamada H, et al. Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells. 2002;20(4):279-283.
64. Atmaca-Sonmez P, Li Y, Yamauchi Y, et al. Systemically transferred hematopoietic stem cells home to the subretinal space and express RPE-65 in a mouse model of retinal pigment epithelium damage. Exp Eye Res. 2006;83(5):1295-1302.
65. Kumar A, Pahwa VK, Tandon R, Kumar L, Mohanty S. Use of autologous bone marrow derived stem cells for rehabilitation of patients with dry age related macular degeneration and retinitis pigmentosa: phase-1 clinical trial. Indian J Med Paediatr Oncol. 2005;26 Suppl 3: 12-14.
66. Blind World Magazine. Stem cell promise cure for vision loss. 2006 Apr 19. Available from: http://www.home.earth-link.net/blindworld2/MEDICAL/6-04-19-01.htm. Accessed May 22, 2007.
67. Blind World Magazine. Retinitis pigmentosa (RP) patient gets stem cell implant. 2006 May 5. Available from: http://www.home.earthlink.net/blindworld2/MEIDCAL/6-05-05-02.htm. Accessed May 22, 2007.
68. Trounson A. New perspectives in human stem cell therapeutic research. BMC Med. 2009;7:29.
69. Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U. Neutrally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the sub retinal space. Invest Ophthalmol Vis Sci. 2004;45(12):4251-4255.
70. Lanza R, Rosenthal N. The stem cell challenge. Sci Am. 2004; 290(6):92-99.
71. Schraermeyer U, Thumann G, Luther T, et al. Sub retinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats. Cell Transplant. 2001;10(8):673-680.
72. Lamba DA, Karl MO, Ware CB, Reh TA. Effcient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U SA. 2006;103(34):12769-12774.
73. Coffey PJ, Girman S, Wang SM, et al. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci. 2002;5(1):53-56.
74. Girman SV, Wang S, Lund RD. Cortical visual functions can be preserved by sub retinal RPE cell grafting in RCS rats. Vision Res. 2003;43(17):1817-1827.
75. Lamba DA, Gust J, Rey TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crxdefcient mice. Cell Stem Cell. 2009;4(1):73-79.
76. Corneo B, Temple S. Sense and serendipity aid RPE generation. Cell Stem Cell. 2009;5(4):347-348.
77. Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27(9):2126-2135.
78. Idelson M, Alper R, Obolensky A, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell. 2009;5(4):396-408.
79. Haruta M, Sasai Y, Kawasaki H, et al. In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest Ophthalmol Vis Sci. 2004;45(3):1020-1025.
80. Osakada F, Ikeda H, Mandai M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol. 2008;26(2):215-224.
81. Nistor G, Seiler MJ, Yan F, Ferguson D, Keirstead HS. Three- dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells. J Neurosci Methods. 2010;190(1):63-70.
82. Vugler A, Lawrence J, Walsh J, et al. Embryonic stem cells and retinal repair. Mech Dev. 2007;124(11-12):807-829.
83. Alge CS, Suppmann S, Priglinger SG, et al. Comparative proteome analysis of native differentiated and cultured human RPE cells. Invest Ophthalmol Vis Sci. 2003;44(8):3629-3641.
84. Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specifc calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U SA. 1995;92(20):9176-9180.
85. Parameswaran S, Balasubramanian S, Babai N, et al. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells. 2010;28(4): 695-703.
86. The London Project to Cure Blindness. London: UCL Institute of Ophthalmology; 2007. Available from: http://thelondonproject.org/aboutus/index.aspx?id=1258. Accessed May 14, 2010.
87. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
88. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872.
89. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.
90. Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. 2009;27(10):2427-2434.
91. Carr AJ, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 2009;4(12):e8152.
92. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949-953.
93. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324(5928):797-801.
94. Lyssiotis CA, Foreman RK, Staerk J, et al. Reprogramming of murine fbroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U SA. 2009;106(22): 8912-8917.
95. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4(6):472-476.
96. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381-384.
97. Liao JL, Yu J, Huang K, et al. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum Mol Genet. 2010;19(21):4229-4238.
98. Mooney I, LaMotte J. A review of the potential to restore vision with stem cells. Clin Exp Optom. 2008;91(1):78-84.
99. Takahashi M, Palmer TD, Takahashi J, Gage FH. Widespread integration and survival of adult derived neural progenitor cells in the developing optic retina. Mol Cell Neurosci. 1998;12(6): 340-348.
100. Stuermer CA, Bastmeyer M. The retinal axon's path finding to the optic disk. Prog Neurobiol. 2000;62(2):197-214.
101. MacLaren RE. Regeneration and transplantation of the optic nerve: developing a clinical strategy. Br J Ophthalmol. 1998;82(5):577-583.
102. Weibel D, Cadelli D, Schwab ME. Regeneration of lesioned rat optic nerve fbers is improved after neutralization of myelin-associated neurite growth inhibitors. Brain Res. 1994;642(1-2):259-266.
103. Schwab ME, Caroni P. Oligodendrocytes and CNS myelin are non permissive substrates for neurite growth and fbroblast spreading in vitro. J Neurosci. 1998;8(1):2381-2393.
104. Thanos S, Naskar R, Heiduschka P. Regenerating ganglion cell axons in the adult rat establish retinofugal topography and restore visual function. Exp Brain Res. 1997;114(3):483-491.